Kohl’s Co. (NYSE:KSS) Shares Purchased by Meyer Handelman Co.
Meyer Handelman Co. boosted its position in Kohl’s Co. (NYSE:KSS) by 27.6% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,700 shares of the company’s stock after purchasing an additional 2,100 shares during the period. Meyer Handelman Co.’s holdings in Kohl’s were worth $461,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also recently made changes to their positions in the stock. Cullen Frost Bankers Inc. acquired a new stake in shares of Kohl’s during the 1st quarter valued at approximately $33,000. Liberty Wealth Management LLC acquired a new stake in shares of Kohl’s during the 4th quarter valued at approximately $36,000. Princeton Capital Management LLC lifted its position in shares of Kohl’s by 94.3% during the 1st quarter. Princeton Capital Management LLC now owns 544 shares of the company’s stock valued at $37,000 after acquiring an additional 264 shares during the period. Thor Advisors LLC acquired a new stake in shares of Kohl’s during the 1st quarter valued at approximately $50,000. Finally, Machina Capital S.A.S. acquired a new stake in shares of Kohl’s during the 4th quarter valued at approximately $52,000.
A number of equities research analysts have recently issued reports on KSS shares. TheStreet upgraded shares of Sensient Technologies from a “c+” rating to a “b-” rating in a research report on Tuesday, June 18th. ValuEngine downgraded shares of Universal Electronics from a “strong-buy” rating to a “buy” rating in a research report on Thursday, June 6th. UBS Group reduced their price target on shares of VF from $97.00 to $87.00 and set a “neutral” rating for the company in a research report on Friday, May 24th. Atlantic Securities downgraded shares of Kohl’s from a “neutral” rating to an “underweight” rating and set a $42.00 price target for the company. in a research report on Tuesday, June 4th. Finally, Wedbush set a $69.00 price target on shares of Albireo Pharma and gave the company a “buy” rating in a research report on Thursday, May 23rd. Four analysts have rated the stock with a sell rating, nine have given a hold rating and eight have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $69.67.
Kohl’s (NYSE:KSS) last released its earnings results on Tuesday, May 21st. The company reported $0.61 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.67 by ($0.06). The firm had revenue of $3.82 billion during the quarter, compared to analysts’ expectations of $3.97 billion. Kohl’s had a return on equity of 16.74% and a net margin of 3.91%. The firm’s revenue was down 3.3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.64 earnings per share. As a group, research analysts forecast that Kohl’s Co. will post 5.31 EPS for the current year.
Kohl’s Company Profile
Kohl's Corporation operates as an omni-channel retailer in the United States. Its stores and Website offer apparel, footwear, accessories, beauty, and home products. As of February 3, 2018, it operated 1,158 department stores; a Website Kohls.com; and 12 FILA outlets, and 4 Off-Aisle clearance centers.
See Also: What is an overbought condition?
Receive News & Ratings for Kohl's Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kohl's and related companies with MarketBeat.com's FREE daily email newsletter.